Skip to main content

Table 2 Follow-up of patients with an undetectable bTg

From: Undetectable thyroglobulin makes 123I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer: a retrospective study

 

Undetectable bTg at 6 months

Total

24/24 (100%)

Post-operative risk stratification

- Low risk (n)

15/24 (62.5%)

- Intermediate risk (n)

7/24 (29.2%)

- High risk (n)

2/24 (8.3%)

sTg at 12 months

< 1 ng/mL (n)

24/24 (100%)

≥1 ng/mL (n)

0/24 (0%)

Ultrasound of the neck at 6 months

No remnant (n)

21/24 (87.5%)

Indeterminate results (n)a

3/24 (12.5%)

Remnant (n)

0/24 (0%)

Ultrasound of the neck at 12 months

No remnant (n)

22/24 (91.6%)

Indeterminate results (n)a

2/24 (8.4%)

Remnant (n)

0/24 (0%)

123I WBS at 12 months

No remnant (n)

24 (100%)

Remnant (n)

0 (0%)

TSH (mIU/L) at 6 months

- Mean ± SD

7.07 ± 31.8

- Median

0.87

  1. aPossible remnant described by radiologist without confirmation